Cargando…
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
Although GBP1 (guanylate binding protein 1) was among the first interferon-inducible proteins identified, its function is still largely unknown. Epidermal growth factor receptor (EGFR) activation by amplification or mutation is one of the most frequent genetic lesions in a variety of human tumors. T...
Autores principales: | Li, Ming, Mukasa, Akitake, del-Mar Inda, Maria, Zhang, Jianhua, Chin, Lynda, Cavenee, Webster, Furnari, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244036/ https://www.ncbi.nlm.nih.gov/pubmed/22162832 http://dx.doi.org/10.1084/jem.20111102 |
Ejemplares similares
-
Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2010) -
Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2011) -
Guanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth in vivo but not in vitro
por: Lan, Qing, et al.
Publicado: (2016) -
A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
por: Read, Renee D., et al.
Publicado: (2009) -
Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks
por: Gomez, German G., et al.
Publicado: (2013)